Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Prg S&Tech Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner working across 1 distinct art unit. The concentration of the portfolio suggests a highly specific focus for the company's current patent prosecution efforts within this technical field. The alignment of the pending action with a specific examiner and art unit provides a clear path for monitoring prosecution trends.
HOERNER, PAUL ELLSWORTH is the busiest examiner for this portfolio, currently handling 1 busiest examiner pending office action. This action accounts for the total volume of pending work for the company. Because the portfolio is limited to the distinct examiner and art unit previously mentioned, the prosecution outcome for the company is currently tied to the specific examination style of HOERNER, PAUL ELLSWORTH. Practitioners must tailor their responses to the specific requirements of the Biotechnology & Pharmaceuticals area while addressing the concerns of this examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOERNER, PAUL ELLSWORTH | 1 | 50.6% | +62.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726803 | GRANULES COMPRISING PROGERININ, AND SACHETS USING SAME | HOERNER, PAUL ELLSWORTH | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18726803 | GRANULES COMPRISING PROGERININ, AND SACHETS USING SAME | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Non-Final OA | — | Pending | Jul 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPrg S&Tech Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Paul Ellsworth Hoerner has the most, with 1 of Prg S&Tech Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
